Literature DB >> 15681154

Humoral immune response against soluble and fractionate antigens in experimental sporotrichosis.

Rosana C Nascimento1, Sandro Rogério Almeida.   

Abstract

Sporotrichosis is a chronic granulomatous mycosis caused by the dimorphic fungus Sporothrix schenckii, which is widely distributed in nature, and presents a saprophytic mycelial form on plant debris and soil. The immunological mechanisms involved in the prevention and control of sporotrichosis are not yet fully understood. In this study, mice were studied after infection with Sporothrix schenckii. In the first week after infection, fungal loading increased and thence decreased drastically 14 days after infection. Analysis by immunoblotting showed that the sera of all mice tested had antibodies reacting only with a 70 kDa antigen, with predominance of IgG1 and IgG3. Taken together, our results show that antigens from S. schenckii induced a specific humoral response in infected mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15681154     DOI: 10.1016/j.femsim.2004.08.004

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  22 in total

1.  Use of mycelial-phase Sporothrix schenckii exoantigens in an enzyme-linked immunosorbent assay for diagnosis of sporotrichosis by antibody detection.

Authors:  Rodrigo Almeida-Paes; Monique A Pimenta; Claudia Vera Pizzini; Paulo Cezar F Monteiro; José Mauro Peralta; Joshua D Nosanchuk; Rosely Maria Zancopé-Oliveira
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

Review 2.  Fungal infections in animals: a patchwork of different situations.

Authors:  Seyedmojtaba Seyedmousavi; Sandra de M G Bosco; Sybren de Hoog; Frank Ebel; Daniel Elad; Renata R Gomes; Ilse D Jacobsen; Henrik Elvang Jensen; An Martel; Bernard Mignon; Frank Pasmans; Elena Piecková; Anderson Messias Rodrigues; Karuna Singh; Vania A Vicente; Gudrun Wibbelt; Nathan P Wiederhold; Jacques Guillot
Journal:  Med Mycol       Date:  2018-04-01       Impact factor: 4.076

Review 3.  Sporothrix schenckii and Sporotrichosis.

Authors:  Mônica Bastos de Lima Barros; Rodrigo de Almeida Paes; Armando Oliveira Schubach
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

4.  Lymphocutaneous and nasal sporotrichosis in a dog from southern Italy: case report.

Authors:  Claudia Cafarchia; Mariateresa Sasanelli; Riccardo P Lia; Donato de Caprariis; Jacques Guillot; Domenico Otranto
Journal:  Mycopathologia       Date:  2007-02-10       Impact factor: 2.574

5.  The predominance of alternatively activated macrophages following challenge with cell wall peptide-polysaccharide after prior infection with Sporothrix schenckii.

Authors:  Pamela Alegranci; Livia Carolina de Abreu Ribeiro; Lucas Souza Ferreira; Thais de Cássia Negrini; Danielle Cardoso Geraldo Maia; Aline Tansini; Amanda Costa Gonçalves; Marisa Campos Polesi Placeres; Iracilda Zeppone Carlos
Journal:  Mycopathologia       Date:  2013-05-18       Impact factor: 2.574

Review 6.  Molecular Components of the Sporothrix schenckii Complex that Induce Immune Response.

Authors:  Carlos A Alba-Fierro; Armando Pérez-Torres; Conchita Toriello; Yolanda Romo-Lozano; Everardo López-Romero; Estela Ruiz-Baca
Journal:  Curr Microbiol       Date:  2016-04-27       Impact factor: 2.188

7.  Immunoglobulins G, M, and A against Sporothrix schenckii exoantigens in patients with sporotrichosis before and during treatment with itraconazole.

Authors:  Rodrigo Almeida-Paes; Monique Amorim Pimenta; Paulo Cezar F Monteiro; Joshua D Nosanchuk; Rosely Maria Zancopé-Oliveira
Journal:  Clin Vaccine Immunol       Date:  2007-07-18

8.  Sporothrix schenckii Cell Wall Peptidorhamnomannans.

Authors:  Leila M Lopes-Bezerra
Journal:  Front Microbiol       Date:  2011-12-21       Impact factor: 5.640

Review 9.  Biological and Clinical Attributes of Sporothrix globosa, a Causative Agent of Sporotrichosis.

Authors:  Laura C García-Carnero; Héctor M Mora-Montes; Nallely Nava-Pérez; Lisset G Neri-García; Oscar E Romero-González; Joshua A Terrones-Cruz
Journal:  Infect Drug Resist       Date:  2022-04-22       Impact factor: 4.177

10.  Therapeutic monoclonal antibody for sporotrichosis.

Authors:  Sandro R Almeida
Journal:  Front Microbiol       Date:  2012-11-28       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.